Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Payables (2020 - 2025)

Historic Payables for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to $10.7 million.

  • Ginkgo Bioworks Holdings' Payables fell 3182.17% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year decrease of 3182.17%. This contributed to the annual value of $14.2 million for FY2024, which is 5197.9% up from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Payables is $10.7 million, which was down 3182.17% from $11.2 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Payables peaked at $35.3 million during Q1 2022, and registered a low of $1.4 million during Q1 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' Payables averaged around $14.0 million, with its median value being $11.3 million (2025).
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Payables soared by 237971.43% in 2022 and then plummeted by 5826.26% in 2025.
  • Ginkgo Bioworks Holdings' Payables (Quarter) stood at $8.2 million in 2021, then increased by 27.62% to $10.5 million in 2022, then fell by 10.79% to $9.3 million in 2023, then soared by 51.98% to $14.2 million in 2024, then dropped by 24.45% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $11.2 million for Q2 2025, and $11.3 million during Q1 2025.